Systematic review with meta-analysis: mortality in acute severe ulcerative colitis

被引:63
|
作者
Dong, Catherine [1 ,2 ]
Metzger, Marie [3 ]
Holsbo, Einar [4 ]
Perduca, Vittorio [3 ,5 ]
Carbonnel, Franck [1 ,2 ,3 ]
机构
[1] Hop Bicetre, Assistance Publ Hop Paris, Dept Gastroenterol, F-94275 Le Kremlin Bicetre, France
[2] Univ Paris Saclay, F-94275 Le Kremlin Bicetre, France
[3] Paris Saclay Univ, Inserm U1018, Ctr Res Epidemiol & Populat Hlth, Villejuif, France
[4] UiT Arctic Univ Norway, Dept Comp Sci, Tromso, Norway
[5] Univ Paris, Univ Paris Descartes, MAP5 Lab UMR CNRS 8145, Paris, France
关键词
acute severe ulcerative colitis; age; mortality; population-based; referral centres; INFLIXIMAB SALVAGE THERAPY; INFLAMMATORY-BOWEL-DISEASE; RESCUE THERAPY; HOSPITALIZED-PATIENTS; COLECTOMY RATE; CROHNS-DISEASE; CYCLOSPORINE; OUTCOMES; EFFICACY; CORTICOSTEROIDS;
D O I
10.1111/apt.15592
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Acute severe ulcerative colitis (ASUC) is a life-threatening condition. Mortality in ASUC decreased in published series but there is uncertainty as to whether this also applies to the real-life setting. Aim: To perform a systematic review and meta-analysis of mortality in ASUC in studies from referral centres and in population-based studies, separately and combined. A second aim was to identify risk factors of mortality in ASUC. Methods: We searched pubmed and embase from 1998 to 2016, to identify studies that reported 3-month or 12-month mortalities of acute UC in adult patients treated in referral centres, and in population-based studies. Results: Six population-based studies with 741 743 patients and 47 referral centre-based studies with 2556 patients were included. The pooled 3-month and 12-month mortalities were respectively 0.84% and 1.01%. Advanced age was significantly associated with both 3 mont and 12 month mortalities (OR = 1.15 per year, 95% CI: 1.10-1.20 and OR = 1.19 per year, 95% CI: 1.15-1.23 respectively). The pooled 3-month and 12-month mortalities were 0.78% and 0.85% in studies with median age of less than 50 and 2.81% and 4.17% in studies with median age of 50 or more, respectively. After adjustment for age, 3-month and 12-month mortalities did not differ between population-based and referral centre-based studies. Conclusions: Mortality in acute severe ulcerative colitis is approximately 1%; it is higher in older patients. Efforts should be made to improve the care of elderly patients with severe UC.
引用
收藏
页码:8 / 33
页数:26
相关论文
共 50 条
  • [1] Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis
    Choy, Matthew C.
    Seah, Dean
    Faleck, David M.
    Shah, Shailja C.
    Chao, Che-Yung
    An, Yoon-Kyo
    Radford-Smith, Graham
    Bessissow, Talat
    Dubinsky, Marla C.
    Ford, Alexander C.
    Churilov, Leonid
    Yeomans, Neville D.
    De Cruz, Peter P.
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (07) : 1169 - 1186
  • [2] INFLIXIMAB SALVAGE THERAPY IN ACUTE SEVERE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Choy, Matthew C.
    Seah, Dean
    Faleck, David
    Shah, Shailja
    Al Khoury, Alex
    An, Yoon Kyo
    Radford-Smith, Graham L.
    Bessissow, Talat
    Ford, Alexander C.
    Dubinsky, Marla
    Yeomans, Neville
    De Cruz, Peter
    GASTROENTEROLOGY, 2018, 154 (06) : S840 - S840
  • [3] EFFICACY AND SAFETY OF UPADACITINIB FOR ACUTE SEVERE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Patel, Armaan
    Hassan, Syed Adeel
    Sulbaran, Marianny
    EL-Najjar, Yassin
    Touma, Mary-Joe
    Perry, Courtney
    Flomenhoft, Deborah
    Barrett, Terrence
    Kinnucan, Jami
    Higgins, Peter
    Fudman, David
    Berinstein, Jeffrey
    INFLAMMATORY BOWEL DISEASES, 2025, 31 : S72 - S73
  • [4] Infliximab salvage therapy in acute severe ulcerative colitis: A systematic review and meta-analysis
    Choy, M. C.
    Seah, D.
    Faleck, D. M.
    Shah, S. C.
    Al-Khoury, A.
    An, Y. -K.
    Radford-Smith, G.
    Bessissow, T.
    Ford, A. C.
    Dubinksy, M.
    Yeomans, N.
    De Cruz, P.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S380 - S380
  • [5] Predictors for colectomy in patients with acute severe ulcerative colitis: a systematic review and meta-analysis
    Zheng, Jieqi
    Fan, Zinan
    Li, Chao
    Wang, Daiyue
    Zhang, Shenghong
    Chen, Rirong
    BMJ OPEN GASTROENTEROLOGY, 2024, 11 (01):
  • [6] Effectiveness of adalimumab in severe ulcerative colitis: A systematic review and a meta-analysis
    Azadbakht, Saleh
    Seighali, Masomeh
    Azadbakht, Salehe
    Azadbakht, Morteza
    HEALTH SCIENCE REPORTS, 2024, 7 (07)
  • [7] Tofacitinib for Acute Severe Ulcerative Colitis: A Meta-Analysis
    Pimpinelli, Marcella
    Bhurwal, Abhishek
    Mutneja, Hemant
    Attar, Bashar
    Seril, Darren
    Chen, Lea Ann
    Brant, Steven
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 : S20 - S20
  • [8] CICLOSPORIN IN ACUTE SEVERE ULCERATIVE COLITIS: A META-ANALYSIS
    Krishnamoorthy, R.
    Abrams, K. R.
    Guthrie, N.
    Samuel, S.
    Thomas, T.
    GUT, 2012, 61 : A394 - A394
  • [9] Moxibustion for ulcerative colitis: a systematic review and meta-analysis
    Dong-Hyo Lee
    Jong-In Kim
    Myeong Soo Lee
    Tae-Young Choi
    Sun-Mi Choi
    Edzard Ernst
    BMC Gastroenterology, 10
  • [10] Moxibustion for ulcerative colitis: a systematic review and meta-analysis
    Lee, Dong-Hyo
    Kim, Jong-In
    Lee, Myeong Soo
    Choi, Tae-Young
    Choi, Sun-Mi
    Ernst, Edzard
    BMC GASTROENTEROLOGY, 2010, 10